Marketing

Marketing

K is for Kerendia as Bayer reads the ABCs of CKD

Bayer is going back to the alphabet to explain the benefits of its new chronic disease drug Kerendia in its latest TV ad.
Ben Adams Aug 19, 2022 8:20am

Clarus' fate in limbo as lead drug Jatenzo sputters

Aug 19, 2022 10:35am
image-icon

Convergence of Marketing to Consumers and Healthcare Personnel,

Oct 25, 2021 11:39pm

BeiGene, Ontada team on campaign for better cancer drug access

Aug 19, 2022 9:50am
image-icon

Improving Patient Position by Increasing Dialog, Education at Po

Oct 25, 2021 11:31pm

Setback at Lundbeck: CGRP migraine drug Vyepti hits trial snag

Aug 18, 2022 12:01pm
More News

Horizon helps kids and families with cystinosis prepare school

Aug 18, 2022 11:29am

Endo files for bankruptcy, signs $450M opioid settlement

Aug 17, 2022 2:20pm

UPDATED: Bluebird's $2.8M gene therapy Zynteglo wins FDA backing

Aug 17, 2022 1:55pm

Amgen backs Global Healthy Living Foundation psoriasis campaign

Aug 17, 2022 11:56am